Skip to search boxSkip to navigationSkip to main content

Nutritional Support System (NSS) as a New Therapeutic Strategy for Cerebral Palsy

Research Output: Contribution to journal Article Peer-review

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 271-277 (7 pages)

Journal (Volume, Issue Number)

CNS and Neurological Disorders - Drug Targets (Volume 23, Issue 3)

Publication milestones

  • Published - 01/01/2024

Publication status

Published - 01/01/2024

ISSN

1871-5273

Publication IDs

  • Scopus: 85182091316
  • PubMed: 37005522

Abstract

Cerebral palsy (CP) is part of a group of nonprogressive motor disorders. The disease affects movement and posture and constitutes the most frequent cause of motor disability in childhood. CP is characterized by spasticity, reflecting lesions in the pyramidal pathway. Treatment is currently focused on physical rehabilitation, and the annual progression of the disease is 2-3%. About 60% of these patients present severe degrees of malnutrition associated with dysphagia, gastrointestinal ab-normalities, malabsorption, increased metabolism, and depression. These alterations promote sarcope-nia functional dependence and affect the quality of life and delay the evolution of motor skills. Cur-rently, there is evidence that the supplementation of several nutrients, dietary correction, and probiot-ics can improve neurological response by stimulating neuroplasticity, neuroregeneration, neurogene-sis, and myelination. This therapeutic strategy could shorten the response period to treatment and increase both gross and fine motor skills. The interaction of nutrients and functional foods integrating a Nutritional Support System (NSS) has shown greater efficiency in neurological stimulation than when nutrients are supplied separately. The most studied elements in the neurological response are gluta-mine, arginine, zinc, selenium, cholecalciferol, nicotinic acid, thiamine, pyridoxine, folate, cobalamin, Spirulina, omega-3 fatty acids, ascorbic acid, glycine, tryptophan, and probiotics. The NSS represents a therapeutic alternative that will restore neurological function in patients with spasticity and pyramidal pathway lesions, both characteristics of patients with CP.